UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063685
Receipt number R000072888
Scientific Title Intestinal Carriage of Antimicrobial-Resistant Gram-Negative Bacteria Across Community, Healthcare, and Long-Term Care Settings in Japan: A Systematic Review and Meta-analysis
Date of disclosure of the study information 2026/11/18
Last modified on 2026/11/18 20:44:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intestinal Carriage of Antimicrobial-Resistant Gram-Negative Bacteria Across Community, Healthcare, and Long-Term Care Settings in Japan: A Systematic Review and Meta-analysis

Acronym

Japan AMR-GNB Carriage Study

Scientific Title

Intestinal Carriage of Antimicrobial-Resistant Gram-Negative Bacteria Across Community, Healthcare, and Long-Term Care Settings in Japan: A Systematic Review and Meta-analysis

Scientific Title:Acronym

Japan AMR-GNB Intestinal Carriage SRMA

Region

Japan


Condition

Condition

Intestinal carriage of antimicrobial-resistant Gram-negative bacteria

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To systematically evaluate the prevalence of intestinal carriage of antimicrobial-resistant Gram-negative bacteria among community-dwelling individuals, including healthy individuals, outpatients, patients admitted to acute-care and long-term care hospitals, individuals receiving home healthcare, and residents of residential care facilities in Japan. The study will also assess differences in carriage prevalence by resistance phenotype and population or facility setting, as well as acquisition, persistence, clearance, and factors associated with intestinal carriage.

Basic objectives2

Others

Basic objectives -Others

Systematic review and meta-analysis of the prevalence of intestinal carriage of antimicrobial-resistant Gram-negative bacteria in Japan

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of intestinal carriage of antimicrobial-resistant Gram-negative bacteria in Japan, defined as the proportion of colonized individuals among those examined, and assessed by resistance phenotype, population or facility setting, and age group.

Key secondary outcomes

1. Acquisition, persistence, and clearance proportions of intestinal carriage of antimicrobial-resistant Gram-negative bacteria.
2. Factors associated with intestinal carriage of antimicrobial-resistant Gram-negative bacteria.
3. Differences in carriage prevalence according to microbiological methods, resistance definitions, study period, and geographic region.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Studies conducted in Japan.
2. Studies involving community-dwelling individuals, including healthy individuals, outpatients, hospitalized patients, individuals receiving home healthcare, or residents of long-term care and other residential care facilities.
3. Studies assessing intestinal carriage of antimicrobial-resistant Gram-negative bacteria using stool specimens or rectal swabs.
4. Studies reporting sufficient data to evaluate carriage prevalence or longitudinal carriage outcomes, including acquisition, persistence, or clearance.
5. Original research articles published in Japanese or English.

Key exclusion criteria

1. Studies conducted outside Japan.
2. Studies using only specimens other than stool or rectal swabs.
3. Studies examining only clinical isolates without assessing intestinal carriage.
4. Case reports, review articles, conference abstracts, and other non-original publications.
5. Studies without sufficient data to evaluate carriage prevalence or longitudinal carriage outcomes.
6. Duplicate reports from overlapping study populations. However, complementary data on different outcomes may be used.

Target sample size



Research contact person

Name of lead principal investigator

1st name Hitoshi
Middle name
Last name Kawasuji

Organization

University of Toyama

Division name

Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly

Zip code

930-0194

Address

2630 Sugitani, Toyama, Toyama 930-0194, Japan

TEL

076-434-2281

Email

kawasuji@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name Hitoshi
Middle name
Last name Kawasuji

Organization

University of Toyama

Division name

Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly

Zip code

930-0194

Address

2630 Sugitani, Toyama, Toyama 930-0194, Japan

TEL

076-434-2281

Homepage URL


Email

kawasuji@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

University of Toyama

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Not applicable (systematic review and meta-analysis).

Address

Not applicable

Tel

Not applicable

Email

Not applicable


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 11 Month 18 Day

Date of IRB

2026 Year 11 Month 18 Day

Anticipated trial start date

2026 Year 11 Month 18 Day

Last follow-up date

2026 Year 11 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This systematic review and meta-analysis will follow PRISMA 2020 and assess intestinal carriage of antimicrobial-resistant Gram-negative bacteria in Japan. PubMed/MEDLINE, Ichushi-Web, and Embase will be searched without publication-year limits, supplemented by citation tracking. Original articles in Japanese or English will be eligible. Two reviewers will independently assess eligibility and resolve disagreements by discussion. Populations will be classified as community, outpatient, acute-care hospital, long-term care hospital, residential care facility, or home healthcare. Community populations will be further classified as healthy individuals, health checkup participants, or other residents, and residential care facilities by type, where possible. Age-group analyses will be considered. The primary outcome is participant-level intestinal carriage prevalence, analyzed separately by resistance phenotype (ESBL, third-generation cephalosporin resistance, AmpC, carbapenem resistance, and carbapenemase production). Where studies are sufficiently comparable, random-effects meta-analysis will estimate pooled prevalence and 95% confidence intervals. Heterogeneity will be assessed using the I-squared (I2) statistic; subgroup and sensitivity analyses will be considered. Secondary outcomes include acquisition, persistence, clearance, and factors associated with carriage. Longitudinal data will be interpreted considering follow-up duration and definitions; narrative synthesis will be used when pooling is inappropriate. Overlapping cohorts and repeated specimens will not be double-counted. Authors may be contacted for aggregate subgroup data.


Management information

Registered date

2026 Year 11 Month 18 Day

Last modified on

2026 Year 11 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072888